Mind Matters Foundation, USA

Abstract Title: SynTheraX-OncoFusion: A CRISPR-Free, AI-Driven RNA Therapeutics Platform for Predicting and Suppressing Hyperplastic Resistance via HCRN Mapping, Synthetic siRNA Logic Gates, and 3D-Enabled Drug Design-Anchored in Glioblastoma with Pan-Cancer Translational Applicability

Hefei Comprehensive National Science Center, China

Abstract Title: Synergistic Frontiers in Oncology: Integrating Antibody-Drug Conjugates and Immune Checkpoint Inhibitors for Tumor Microenvironment Reprogramming

Fore Medicine Co. Ltd, China

Abstract Title: Next Generation Cancer Drug Discovery in the Post Immuno-Oncology Era